Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study.

José Damas, Margrethe Storm, Lok Raj Pandey, Gaetano Marrone, Keshab Deuba
Author Information
  1. José Damas: Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  2. Margrethe Storm: Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  3. Lok Raj Pandey: National Centre for AIDS and STD Control, Ministry of Health and Population, Kathmandu, Nepal.
  4. Gaetano Marrone: Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  5. Keshab Deuba: Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden. ORCID

Abstract

BACKGROUND: People who inject drugs (PWID) are at great risk of HIV and Hepatitis C Virus (HCV). In order to properly design interventions and develop programmes for women who inject drugs, this study assessed the prevalence of HIV, Hepatitis B, Hepatitis C, and syphilis and its risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal.
METHODS: Through modified network sampling in three districts in the Kathmandu Valley, Nepal, this cross-sectional study enrolled a total of 160 women who inject drugs. Participants' serum samples were tested for HIV, HCV, Hepatitis B virus (HBV) and syphilis and risk behaviours were assessed through a structured questionnaire. Primary outcome variables were HIV, HCV, HBV and syphilis prevalence, and secondary outcome variables were sharing needles in the past month and using condom in last sexual intercourse. Stepwise logistic regression was used to determine micro- and macroenvironmental factors associated with secondary outcomes.
RESULTS: The prevalence of HIV, HCV, and HBV was 8.8%, 21.3%, and 1.9%, respectively. HIV-HCV co-infection rate was 5.6%. Fifteen percent of women who inject drugs reported transactional sex for drugs or money. One in four women who inject drugs (27.5%) reported that they were imprisoned or detained for drug related reasons. In multivariable analysis, women living with HIV who inject drugs were almost four times more likely to use a previously used needle/syringe than women who inject drugs who were HIV negative (aOR: 4.2 CI: 1.1-15.9,  = 0.03), but were almost four times more likely to use a condom during sexual intercourse (aOR: 3.5 CI: 1.1-28.9,  = 0.03). Enrolment in family planning was the main determinant for using condoms in last sexual intercourse (aOR 4.9 CI: 1.6-16.7,  = 0.006). Participants with access to HIV test and counselling (HTC) services were less likely to share needles (aOR: 0.3, 95% CI: 0.1-0.8,  = 0.01).
CONCLUSION: Prevalence of HIV and HCV is high among women who inject drugs in Kathmandu valley of Nepal. Women who inject drugs enrolled in national programmes such as family planning and HTC were positively associated with condom use, and less likely to share needles.

Keywords

References

  1. Nepal J Epidemiol. 2016 Dec 31;6(4):620-630 [PMID: 28804674]
  2. Lancet Infect Dis. 2016 Dec;16(12):1385-1398 [PMID: 27665254]
  3. Infect Dis Obstet Gynecol. 2018 Aug 26;2018:4980396 [PMID: 30224859]
  4. J Int Assoc Provid AIDS Care. 2017 Jul/Aug;16(4):338-346 [PMID: 26527219]
  5. AIDS. 1991 Jan;5(1):77-83 [PMID: 2059364]
  6. PLoS One. 2015 Aug 11;10(8):e0134455 [PMID: 26263394]
  7. Int J Drug Policy. 2015 Dec;26(12):1244-50 [PMID: 26282716]
  8. Lancet. 2016 Apr 2;387(10026):1427-1480 [PMID: 27021149]
  9. BMC Womens Health. 2011 May 25;11:19 [PMID: 21612603]
  10. Int J Drug Policy. 2015 Feb;26 Suppl 1:S16-21 [PMID: 25277726]
  11. J Viral Hepat. 2017 Feb;24(2):117-127 [PMID: 27790803]
  12. Subst Use Misuse. 2015;50(10):1332-40 [PMID: 26441158]
  13. BMJ. 2018 Apr 16;361:k1679 [PMID: 29661805]
  14. Lancet. 2011 Aug 13;378(9791):571-83 [PMID: 21802134]
  15. Sex Transm Dis. 2011 Jun;38(6):499-502 [PMID: 21183861]
  16. Drug Alcohol Rev. 2018 Mar;37(3):333-339 [PMID: 28762584]
  17. J Urban Health. 2003 Mar;80(1):137-46 [PMID: 12612103]
  18. J Int Assoc Provid AIDS Care. 2014 May-Jun;13(3):277-83 [PMID: 24056798]
  19. BMC Public Health. 2015 Jul 30;15:726 [PMID: 26223866]
  20. AIDS Behav. 2017 Apr;21(4):1054-1058 [PMID: 28185022]
  21. AIDS. 1990 May;4(5):449-53 [PMID: 2372379]
  22. Soc Sci Med. 2006 Apr;62(7):1650-71 [PMID: 16198467]
  23. BMC Public Health. 2013 Dec 28;13:1238 [PMID: 24373529]
  24. Harm Reduct J. 2015 Oct 16;12:35 [PMID: 26472467]
  25. Lancet. 2010 Jul 24;376(9737):268-84 [PMID: 20650523]
  26. Soc Sci Med. 2017 May;180:125-134 [PMID: 28343111]

Word Cloud

Created with Highcharts 10.0.0drugsinjectHIVwomenHCVriskHepatitisKathmanduHBVneedles1likelyCI: = 0CstudyprevalencesyphilisbehavioursamongValleyNepalcondomsexualintercoursefouruseaOR:9programmesassessedBcross-sectionalenrolledoutcomevariablessecondarysharingusinglastusedassociated85reportedtransactionalsexrelatedalmosttimes4033familyplanningHTClessshare0PrevalenceBACKGROUND:PeoplePWIDgreatVirusorderproperlydesigninterventionsdevelopMETHODS:modifiednetworksamplingthreedistrictstotal160Participants'serumsamplestestedvirusstructuredquestionnairePrimarypastmonthStepwiselogisticregressiondeterminemicro-macroenvironmentalfactorsoutcomesRESULTS:8%213%9%respectivelyHIV-HCVco-infectionrate6%FifteenpercentmoneyOne275%imprisoneddetaineddrugreasonsmultivariableanalysislivingpreviouslyneedle/syringenegative21-151-28EnrolmentmaindeterminantcondomsaOR6-167006Participantsaccesstestcounsellingservices95%1-001CONCLUSION:highvalleyWomennationalpositivelyNepal:STIsenvironment

Similar Articles

Cited By